TrustCapital

investment firm

About

The "Fixed Income" Specialists. We know only one business. Fixed income. And over the past 10 years, we have just done one thing.

Details

Founded date
Jan 1, 1994
Operating Status
Active
Investor Type
Venture Capital

The "Fixed Income" Specialists.


We know only one business. Fixed income. And over the past 10 years, we have just done one thing. Specialise in it.

So that we offer the most comprehensive, well researched and customized fixed income solutions.

Trust has invested 200 man years in fixed income business. A business that we believe is at an inflection point. Fixed income of today is not going to be the fixed income of tomorrow. It is getting more specific. Time for specialists.

Derivatives, PMS and Structured products that have so far been restricted to equities are going to be the fixed income needs and options of tomorrow. And Trust is already focusing on it. So that you benefit from our specialization.

Intermediation is getting more value-added. No longer do you need just quotes, you need advise on the direction of the market. You need to evaluate structures and options. You need to know the macro economic trends and link it to interest rates. And more importantly, benefit from it. That's what Trust has been specialising in. To add value to your intermediation.

Investments

Number of Investments
Number of Lead Investments
6
1
TrustCapital has made 6 investments. Their most recent investment was on Jan 1, 2018, when LoanXpress.com raised $7.80M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 1, 2018 LoanXpress.com
Seed $7.80M Advice Yes
Jun 26, 2013 Complix
Series B €12M Biotechnology
Jul 27, 2011 Dacentec
Series A €6.20M Computer
Jun 20, 2007 Algonomics
Series Unknown €1.50M Bioinformatics
Jun 29, 2006 Clear2Pay
Series D €15.70M Finance

Exits

TrustCapital has had 2 exits. TrustCapital most notable exits include Clear2Pay ,   Algonomics

Date Company Name Exit Type Industry
Sep 3, 2014 Clear2Pay M&A Finance Detail
Nov 3, 2009 Algonomics M&A Bioinformatics Detail